| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701028 | European Journal of Surgical Oncology (EJSO) | 2017 | 6 Pages |
Abstract
Based on the new guidelines for ABD, imprint cytology cannot be considered a beneficial and cost-effective intervention in the surgical treatment of early breast cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Z. Horváth, A. Paszt, Z. Simonka, M. Látos, V. Oláh, D. Nagyszegi, L. Kaizer, Z. Fejes, S. Hamar, E. CsörgÅ, K. Ormándi, M. Lázár, G. Lázár,